Arkolith/Insider Trading/ARQT/Form 4

Curran Terrie

DirectorArcutis Biotherapeutics, Inc. (ARQT) · full profile →Form 4 · filed Aug 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$956K
Net Open-Market Flow
-$956K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 27, 2026Option exercise(M)11K$7.51$84K35K
Aug 27, 2026Sell(S)11K$25.03$279K24K
Aug 27, 2026Option exercise(M)27K$8.63$233K51K
Aug 27, 2026Sell(S)27K$25.03$677K24K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 27, 2026Option exercise(M)11K—$00
Aug 27, 2026Option exercise(M)27K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-059444) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Arcutis Biotherapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp